Reviews
Average rating: 4/5
Physician ( 1 )
-
5
-
4
-
3
-
2
-
1
Average rating: 4.00/5
Total Reviews: 1
-
5
-
4
-
3
-
2
-
1
GLP-1 receptor agonists like liraglutide have become increasingly prominent in type 2 diabetes treatment because they lower blood sugar while promoting significant weight loss. Liraglutide, a daily injection, offers strong evidence for both weight loss and cardiovascular protection, making it a preferred option for patients with obesity or high cardiovascular risk. As a result, it is now often integrated earlier into diabetes treatment regimens.
0